Skip to main content
. Author manuscript; available in PMC: 2020 Sep 17.
Published in final edited form as: Lupus. 2020 Jun 6;29(8):976–982. doi: 10.1177/0961203320929427

Table 1.

Age-standardized participant characteristics, at blood draw, by alcohol consumption, in the NHS/NHS2 study sample (N=1177).

Cumulative Average Alcohol Consumption (g/day)
None >0 - <5 ≥5
Characteristic (n=345) (n=545) (n=287)
Age at blood draw, mean (sdb)a 54.9 (10.6) 55.2 (9.8) 59.2 (9.1)
Pack years, smokers, median (iqrb) 0 (0, 4.0) 0 (0, 15.0) 7.0 (0, 22.0)
Alcohol, g/day, median (iqr) 0 1.2 (0.6, 2.6) 10.2 (7.4, 17.6)
Median tract income, $, mean (sd) 55,947 (20,948) 60,820 (23, 387) 65,459 (25560)
BMI, kg/m2, mean (sd) 28.0 (6.9) 26.6 (5.6) 24.8 (5.0)
Race, n(%)
 Non-black 175 (53.9) 346 (64.9) 236 (79.0)
 Black 170 (46.12) 199 (35.1) 51 (21.0)
Census region of residence, n(%)
 New England 23 (7.2) 43 (8.4) 22 (8.3)
 Mid-Atlantic 102 (30.2) 195 (35.7) 106 (35.7)
 Midwest 85 (24.2) 128 (23.1) 50 (18.8)
 South 46 (12.1) 48 (8.5) 28 (9.8)
 West 89 (26.4) 131 (24.3) 81 (27.4)
Ever oral contraceptive use, n(%) 215 (61.2) 383 (68.6) 192 (70.9)
Menopause/Hormone use, n(%)
 Pre-menopause 128 (37.1) 160 (29.4) 51 (17.8)
 Post-menopause/never 93 (27.0) 176 (32.3) 86 (30.0)
 Post-menopause/past 36 (10.4) 56 (10.3) 25 (8.7)
 Post-menopause/current 88 (25.5) 153 (28.1) 125 (43.6)
Steroid use at blood draw, n(%) 11 (3.3) 22 (4.1) 19 (6.4)
BLyS (pg/ml), median (iqr) 1049.9
(843.0, 1276.3)
1077.1
(869.8, 1315.6)
1021.7
(832.7, 1201.5)
SCF (pg/ml), median (iqr) 1083.4
(944.5, 1278.2)
1053.9
(892.6, 1233.2)
993.9
(855.7, 1169.8)
IFN-α (pg/ml), median (iqr)d 1.7
(0.6, 2.8)
1.6
(0.7, 3.0)
2.0
(0.7, 3.1)
IP-10 (pg/ml), median (iqr)d 59.7
(40.4, 102.0)
58.2
(38.3, 89.6)
59.8
(38.8, 91.4)
IL-10 (pg/ml), median (iqr)d 14.1
(3.4,101.7)
9.8
(2.1, 52.1)
18.7
(2.8, 90.5)
ANA ≥ 1:40 70 (20.1) 135 (24.5) 60 (20.1)
ANA ≥ 1:80 18 (5.2) 47 (8.6) 15 (5.2)
ENAc 12 (3.7) 36 (6.6) 21 (6.5)
dsDNA 2 (.6) 6 (1.1) 2 (.6)
a

Value is not age adjusted.

b

sd: standard deviation; iqr: inter-quartile range.

c

Anti- dsDNA, Sm, Ro/SSA, La/SSB, RNP.

d

Percent below limit of detection: 62.3% (IFN-a), 13.8% (IP-10), 71.9% (IL-10).